1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Deficiency, Vitamin E in 4 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, YR | 1 |
| Nishida, Y | 1 |
| Yoshimi, K | 1 |
| Yasuda, T | 1 |
| Jishage, K | 1 |
| Uchihara, T | 1 |
| Yokota, T | 1 |
| Mizuno, Y | 1 |
| Mochizuki, H | 1 |
| Sutphin, MS | 1 |
| Buckman, TD | 1 |
| Adams, JD | 1 |
| Odunze, IN | 1 |
| Sevanian, A | 1 |
| Hornsby, PJ | 1 |
4 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Deficiency, Vitamin E
| Article | Year |
|---|---|
Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Brain; Corpus Striatum; | 2006 |
Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Catalase; Caudate Nucleu | 1991 |
Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cerebellum; Cerebral Cortex; Corpus St | 1990 |
Parkinson's disease, vitamin E, and mitochondrial energy metabolism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Energy Metabolism; Humans; Mitochondria; Neur | 1989 |